Pfizer (PFE) Current Taxes (2009 - 2026)

Pfizer (PFE) has 18 years of Current Taxes data on file, last reported at $3.1 billion in Q1 2026.

• Current Taxes for Q1 2026 came in at $3.1 billion, up 0.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 0.81% YoY), and the FY2025 annual result was $3.1 billion, up 6.63% from the prior year.
• Current Taxes climbed to $3.1 billion in Q1 2026 per PFE's latest filing, from $3.1 billion in the prior quarter.
• Over five years, Current Taxes peaked at $3.8 billion in Q3 2025 and troughed at $1.6 billion in Q4 2022.
• A 5-year average of $2.9 billion and a median of $3.1 billion in 2022 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2022 and 2023: Current Taxes jumped 126.77% in 2022, then sank 38.2% in 2023.
• A 5-year view of Current Taxes shows it stood at $1.6 billion in 2022, then jumped by 48.02% to $2.3 billion in 2023, then rose by 23.88% to $2.9 billion in 2024, then increased by 6.63% to $3.1 billion in 2025, then rose by 0.87% to $3.1 billion in 2026.
• Business Quant data shows PFE's Current Taxes at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.8 billion in Q3 2025.